SCYX - Scynexis Inc - SEC Form 4 Insider Trading Screener
18 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| P | 2 | +3 | +4 | -2 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-09-06 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.27 | +7,000 | 108,790 | +7% | +$8,890 | ||||||
2018-08-23 | SCYX | Taglietti Marco | CEO | P - Purchase | $1.29 | +25,000 | 429,000 | +6% | +$32,250 | ||||||
2018-03-29 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.36 | +6,000 | 101,790 | +6% | +$8,160 | ||||||
2018-03-08 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.39 | +7,000 | 95,790 | +8% | +$9,730 | ||||||
| D | 2018-03-08 | SCYX | Hastings David C | Dir | P - Purchase | $1.69 | +11,834 | 31,834 | +59% | +$19,999 | |||||
| D | 2018-03-08 | SCYX | Sukenick Scott | GC | P - Purchase | $1.69 | +2,959 | 2,959 | New | +$5,001 | |||||
| D | 2018-03-08 | SCYX | Taglietti Marco | CEO | P - Purchase | $1.69 | +100,000 | 404,000 | +33% | +$169,000 | |||||
| D | 2018-03-08 | SCYX | Francois Eric | CFO | P - Purchase | $1.69 | +5,917 | 24,917 | +31% | +$10,000 | |||||
| D | 2018-03-08 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.69 | +14,790 | 88,790 | +20% | +$24,995 | |||||
2017-09-22 | SCYX | Taglietti Marco | CEO | P - Purchase | $2.23 | +10,000 | 303,000 | +3% | +$22,300 | ||||||
| M | 2017-08-22 | SCYX | Taglietti Marco | CEO | P - Purchase | $1.85 | +5,000 | 292,000 | +2% | +$9,248 | |||||
2017-08-15 | SCYX | Taglietti Marco | CEO | P - Purchase | $1.61 | +10,000 | 287,000 | +4% | +$16,100 | ||||||
2017-08-11 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.55 | +10,000 | 72,000 | +16% | +$15,500 | ||||||
2017-06-21 | SCYX | Hastings David C | Dir | P - Purchase | $1.75 | +20,000 | 20,000 | New | +$35,000 | ||||||
2017-05-12 | SCYX | Taglietti Marco | CEO | P - Purchase | $1.69 | +25,000 | 277,000 | +10% | +$42,250 | ||||||
2017-05-12 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.70 | +15,000 | 62,000 | +32% | +$25,500 | ||||||
2016-12-21 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.30 | +25,000 | 251,000 | +11% | +$82,500 | +3 | -1 | -6 | |||
2016-12-16 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $3.25 | +4,000 | 46,000 | +10% | +$13,000 | +3 | +9 | +3 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |